4C Medical Technologies develops the AltaValve™, a supra-annular transcatheter mitral valve replacement system designed to treat mitral regurgitation in a broader patient population. This technology streamlines the procedure while preserving critical cardiac structures, addressing the limitations of traditional mitral valve therapies.

ABK Biomedical designs and manufactures CNC‑machined, medical‑grade titanium surgical instruments with sub‑micron tolerances for orthopedics, neurosurgery, and cardiovascular procedures. The modular, ergonomically optimized tools integrate radiopaque markers and are fully ISO 13485, FDA QSR, and CE‑certified, enabling hospitals and surgical centers to perform complex interventions with greater precision and reduced procedure time.

The startup develops a therapeutic medical device that utilizes neuromodulation techniques to treat refractory constipation in patients. This device provides a targeted approach to alleviate chronic constipation symptoms, improving patients' quality of life by reducing their reliance on traditional laxatives and invasive procedures.

Avisi Technologies is developing VisiPlate, a nanotechnology-enabled aqueous shunt designed to lower intraocular pressure in patients with open-angle glaucoma. This investigational implant addresses the risk of irreversible blindness by providing a minimally invasive solution that enhances aqueous drainage through a network of microchannels.

The startup develops a wristwatch-type wearable device that monitors heart failure patients by detecting cardiac murmurs, reduced activity, and peripheral coldness. This remote medical treatment system enables early symptom detection, allowing patients to receive timely intervention from home.

Beta Bionics develops the iLet Bionic Pancreas, an insulin delivery system that autonomously calculates and administers insulin doses based on real-time data from continuous glucose monitors. This technology eliminates the need for manual carb counting and insulin dose adjustments, providing a streamlined solution for diabetes management.

BIOMED is a biotechnology platform that utilizes artificial intelligence, machine learning, and 3D bioprinting to develop personalized and precision medicine tailored to individual patient profiles. The company addresses healthcare accessibility by providing targeted drug delivery and predictive modeling to improve health outcomes across diverse demographics.

Butterfly Medical has developed a minimally invasive, implantable device that treats Benign Prostatic Hyperplasia (BPH) by retracting lateral lobes without cutting or burning tissue. This non-surgical solution offers a reversible treatment option for the approximately 30 million men worldwide experiencing BPH symptoms, significantly improving their quality of life.

Digma Medical offers the Endoscopic Gastrointestinal Ablation Device (EGAD), a balloon‑catheter system that delivers near‑infrared laser energy for uniform, depth‑controlled ablation of Barrett’s Esophagus tissue. The single‑use, through‑the‑scope catheter integrates with standard GI endoscopes, provides real‑time imaging‑guided mapping, and eliminates the need for fluoroscopy, general anesthesia, or additional hardware, enabling outpatient treatment.

The startup develops percutaneous transvascular EEG measurement devices that provide less invasive alternatives to traditional EEG methods using subdural or deep electrodes. This technology enables healthcare professionals to conduct preoperative examinations with reduced patient resistance, facilitating the identification of focal localization in intractable epilepsy.

IntraVu develops a sub-2mm disposable arthroscopic scope with a 30-degree side view, enabling single-handed operation for orthopedic diagnostics. This technology minimizes tissue disruption and accelerates patient recovery by allowing physicians to maintain a stable view while manipulating instruments within the joint.

The startup has developed an operation-assisted navigation system that utilizes artificial intelligence to analyze surgical images in real-time, enhancing the cognitive capabilities of surgeons during laparoscopic procedures. This technology aims to improve the safety and effectiveness of endoscopic surgeries by visualizing critical information that is often implicit in surgical practice.

The startup has developed a non-contact device utilizing milliwave radar technology and low-frequency irradiation to detect sleep apnea and hypopnea. This technology enables patients to achieve uninterrupted sleep by addressing the physiological factors that contribute to sleep disorders.

mediVR develops a virtual reality rehabilitation device that provides measurable metrics for assessing patient progress in physical therapy. This technology supports individuals recovering their mobility and daily living skills, particularly benefiting those with neurological conditions or disabilities.

NEX provides a suite of controllable AI image generation tools that utilize IP-consistent models trained on securely stored team data, enabling precise customization of images through multimodal inputs. This technology addresses the inefficiencies in creative workflows by allowing teams to rapidly generate high-quality images tailored to specific project requirements, significantly reducing model development costs and turnaround times.

Palm provides an AI-driven treasury management system that integrates data from banks and existing treasury management systems to generate real-time cash forecasts and funding recommendations. This platform enhances cash visibility and decision-making efficiency for enterprise teams by automating cash flow analysis and reporting.

RA UNLIMITED harnesses solar photovoltaic technology to generate clean and affordable electricity for homes, businesses, and communities in the Philippines. The company addresses the reliance on fossil fuels by providing sustainable energy solutions that create jobs and enhance the quality of life for Filipinos.

Develops bioadhesive technologies inspired by natural adhesives, such as barnacle glue and spider silk, to create rapid, robust bonding solutions for wet, contaminated, and uneven biological surfaces. These technologies address challenges in medical applications, including wound healing and surgical adhesion, by providing coagulation-independent, strain-programmed, and multi-form factor solutions.

Seed is a recruitment application designed to streamline the search for internships by providing students with a transparent and efficient platform to connect with potential employers. The app enhances student engagement in the workplace by simplifying the application process and improving access to relevant opportunities.

SentiAR has developed a holographic 3D visualization platform that provides real-time, interactive views of patient anatomy and catheter positioning during interventional procedures. This technology enhances procedural accuracy and efficiency by consolidating multiple data sources into a single, intuitive interface, enabling clinicians to deliver safer and more precise care.

The startup has developed a synthetic drug carrier platform that utilizes nanotechnology to deliver drugs and nonviral genes to cells via synthetic nanocarriers for subcutaneous nanotherapy. This technology enhances the efficacy and safety of treatments for a variety of diseases by improving drug delivery precision.

SonoMotion is developing a non-invasive medical device platform that utilizes low-pressure ultrasound waves to fragment and reposition kidney stones in awake patients, eliminating the need for general anesthesia and x-ray radiation. This approach addresses the high volume of kidney stone procedures by providing a safer, cost-effective treatment option that can be performed in an office setting.

Spirair provides minimally invasive, bioabsorbable implant systems for otolaryngologists to treat nasal obstruction. Its SeptAlign implant mechanically corrects minor septal deviation, while TurbAlign medializes the middle turbinate, both using a single‑pass, knot‑free delivery that reduces operative time, eliminates extensive dissection, and resorbs as tissue heals, delivering faster recovery and improved airflow.

The startup develops diagnostic and therapeutic devices that utilize neurofeedback technology based on brain circuit markers to identify mental illnesses. This approach enables healthcare providers to deliver targeted treatments, improving patient outcomes in mental health care.